Biobank – CHU Angers

Name of bioresource/bank
Biobank – CHU Angers
Name of Principal Investigator

Title Professor
First name Annick
Last name Barthelaix

Address of institution where award is held

Institution Centre hospitalier Universitaire – IBS
Street Address 4 rue Larrey
City Angers
Postcode 49933

Country

  • France

    • Website
    www.chu-angers.fr
    Contact email (e.g. manager or coordinator)
    [email protected]
    Funding source
    The Universitary Hospital Center is a public health establishement; its activities are funded by the French Health Minister, the French Research minister and the Region Pays de la Loire
    Q1 What conditions does your resource cover?

  • Alzheimer’s disease and other dementias
  • Motor neurone diseases
  • Huntington’s disease
  • Neurodegenerative disease in general

    • Q2a What DNA collection does your resources hold?

  • 101-1000 donors

    • Q2b What cell lines does your resource hold?

  • 1-50 distinct cell lines

    • Q2c What tissue (including post-mortem tissue) does your resource hold?

  • 101-1000 donors

    • Q3 Are human tissues/samples/DNA from

  • Living donors:blood
  • Living donors: blood derivatives
  • Living donors: DNA
  • Living donors: skeletal muscle biopsy
  • Living donors: cerebro-spinal fluid
  • Post-mortem donors: brain
  • Post-mortem donors: spinal cord

    • Q4 Are tissues/samples/DNA from

  • Patients

    • Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:

  • Routinely collected as medical records
  • In a specific study-associated dataset
  • Collected as part of a specific clinical trial(s)

    • Q6 In what form are samples supplied?

  • Primary Samples: Stabilised samples (frozen or fixed)
  • Secondary samples:(derivatives of primary samples)
  • Secondary samples: plasma
  • Secondary samples: DNA
  • Secondary samples: RNA
  • Secondary samples: protein extracts
  • Secondary samples: cell lines derived from primary samples

    • Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?

  • In most samples

    • Q8 What is the status of your tissue/sample/DNA collection?

  • Collection completed and available for use

    • Q9 What are the rules and procedures for access?

  • Apply to PI or co-ordinator at resource
  • Access independent of collaboration with PI
  • Access Committee mechanism
  • Local/ regional access
  • National access
  • International access
  • Access to industry
  • Access for pilot studies permitted
  • Access restricted to peer-reviewed work
  • Resource has own ethics approval so usually no need for separate external ethics approval

    • Biobank – CHU Angers

    Biobanks

    2011

     

     

    Post
    Filter